Clinical Trial Update: A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This is a single-arm, open-label Phase 1/Phase 2 clinical study evaluating the combination of VRT106 with chemotherapy for advanced pancreatic cancer; recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• VRT106

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING